Such monomeric Aβ-clearing mechanisms become inadequate when mutations of APP or PSEN1 or PSEN2 genes cause an overproduction of Aβs as in EOFAD or when they significantly decline with age and fail in LOAD (Tarasoff-Conway et al., 2015). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.